Novel Drug Delivery System (NDDS): Niosomes.
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2012, Vol 1, Issue 3
Abstract
Different carriers like liposomes, niosomes, microspheres, resealed erythrocytes, dendrimers, aquasomes, trasfersomes, ethosomes, phytosomes, nanoparticles etc. are used in novel drug delivery system. Vesicular systems are a novel means of drug delivery that can enhance bioavailability of encapsulated drug and provide therapeutic activity in a controlled manner for a prolonged period of time. Liposomes were the first such system but they suffer from a number of drawbacks including high cost and lack of stability at various pHs. Niosomes are non-ionic surfactant vesicles obtained on hydration of synthetic nonionic surfactants, with or without incorporation of cholesterol or other lipids. Niosomes are one of the best carriers for drug targeting. The basic method of preparation is the same as liposomes i.e. hydration of the lipid phase by aqueous phase which may be either a pure surfactant or a mixture of surfactant with cholesterol. Niosomes are promising vehicle for drug delivery and being non-ionic; it is less toxic and improves the therapeutic index of drug by restricting its action to target cells. Niosomal drug delivery is potentially applicable to many pharmacological agents for their action against various diseases. This review article deals with advantages, preparation, separation of unentrapped drug, factors affecting vesicles size, entrapment efficiency and release characteristics of niosomes, evaluation, applications and Marketed formulations of niosomes.
Authors and Affiliations
Satyanand Tyagi*| President, Tyagi Pharmacy Association & Scientific Writer (Pharmacy), Chattarpur, New Delhi, India-110074., Patel Chirag J| Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Mansarovar, Jaipur, Rajasthan, India-302020., Tarun Parashar| Department of Pharmaceutics , Himalayan Institute of Pharmacy and Research, Rajawala, Dehradun, Uttarakhand, India-248001., Soniya| Department of Pharmaceutics , Himalayan Institute of Pharmacy and Research, Rajawala, Dehradun, Uttarakhand, India-248001.
Keywords
Related Articles
- EP ID EP1559
- DOI -
- Views 460
- Downloads 76
EFFECTS ON HAEMODYNAMICS, BIOCHEMICAL AND HEMATOLOGICAL CHANGES AFTER PRETREATMENT WITH THE KCNQ OPENER RETIGABINE AND DIACYGLYCEROL LIPASE INHIBITOR ON PROPOFOL IN THE MICE
The mechanisms of action of general anesthetics are still being unraveled. Retigabine is a KCNQ/Kv7 channel opener and has potential therapeutic importance for epilepsy. On the other hand, Propofol an inducing general an...
Bedaquiline: A Novel Addition to Anti-Tubercular Armamentarium
In current scenario of rising trend of resistant tuberculosis (TB) and acquired immunodeficiency syndrome (AIDS) co infection with TB, a novel antitubercular drug is a prime need to effectively decrease the disease burde...
ROLE OF BHALLATAKARASAYANA IN CANCER
An integrated approach is required in the management of cancer by using the knowledge gained through various scientific developments. Thousands of traditional compounds are being screened worldwide to validate their effi...
CYTOTOXIC, ANTIMICROBIAL AND ANTIVIRAL EVALUATION OF THE AERIAL PARTS OF SORGHUMVIRGATUMHACK
Sorghum virgatum (Hack) belongs to Poaceae (Graminae) family, which represented in flora of Egypt by four species. It worth noting that nothing was reported about phytochemical and biological investigation of S.virgatum....
DESIGN AND DEVELOPMENT OF SOLID DISPERSION SYSTEM OF ZOLMITRIPTAN
Zolmitriptan is a potent anti-migraine drug. The bioavailability of Zolmitriptan is about 40% via oral dosage forms and problem arises from its low water solubility and dissolution rate. The present study deals with for...